chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain in extremity, Rhinorrhoea
Clinical narrative: PAIN IN NECK; RUNNY NOSE; PAIN IN BOTH ARMS; This spontaneous report received from a patient concerned an 81 year old. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol user, non-smoker, penicillin allergy, sulfa allergy, arthritis, incontinence, and cataracts, and other pre-existing medical conditions included patient did not have any drug abuse/illicit drug use. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced pain in neck. On 09-APR-2021, the subject experienced runny nose. On 09-APR-2021, the subject experienced pain in both arms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in both arms, pain in neck, and runny nose. This report was non-serious.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: BODY ACHE; VOMITING; FEVER; NAUSEA; This spontaneous report received from a patient concerned a 45 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 202A21A, and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced body ache. On 08-APR-2021, the subject experienced vomiting. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, vomiting, and nausea on 09-APR-2021, and was recovering from fever. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Pain, Pyrexia
Clinical narrative: PAIN; SHORTNESS OF BREATH; HEADACHE; FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202821A, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 15:30 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, treatment medications included: paracetamol. On 09-APR-2021, the subject experienced pain. On 09-APR-2021, the subject experienced shortness of breath. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced fever. Laboratory data (dates unspecified) included: COVID-19 PCR test (NR: not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, fever, shortness of breath, and pain. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Myalgia, Pyrexia
Clinical narrative: FEELING TERRIBLE; CHILLS; MUSCLE ACHE; HEADACHES; FEVER; This spontaneous report received from a parent concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced feeling terrible. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced muscle ache. On 10-APR-2021, the subject experienced headaches. On 10-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the muscle ache, headaches, chills, fever and feeling terrible was not reported. This report was non-serious.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Heart rate, Heart rate increased, Pyrexia
Clinical narrative: ELEVATED HEART RATE; FEVER; HEADACHE; This spontaneous report received from a parent concerned a 21 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982 Expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 09:30 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced elevated heart rate. On 09-APR-2021, the subject experienced fever. On 09-APR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 103.5 (units unspecified), and Pulse rate (NR: not provided) 130 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, elevated heart rate, and headache. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Pain, Pain in extremity
Clinical narrative: BODY ACHES; ARM ACHE; CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On APR-2021, the subject experienced body aches. On APR-2021, the subject experienced arm ache. On APR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, arm ache, and chills on APR-2021. This report was non-serious.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, Chills, Headache, Pain
Clinical narrative: STOMACH ACHES; CHILLS; SEVERE FEVER; SEVERE HEADACHES; BODY ACHE; BODY SHAKES; This spontaneous report received from a patient concerned a 38 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included addison's disease, and other pre-existing medical conditions included patient had not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced body ache. On 08-APR-2021, the subject experienced body shakes. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced severe fever. On 08-APR-2021, the subject experienced severe headaches. Laboratory data included: Body temperature (NR: not provided) 103 F. On 09-APR-2021, the subject experienced stomach aches. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body shakes on 09-APR-2021, had not recovered from severe fever, chills, severe headaches, and stomach aches, and the outcome of body ache was not reported. This report was non-serious.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor
Clinical narrative: STOMACH ACHES; CHILLS; SEVERE FEVER; SEVERE HEADACHES; BODY ACHE; BODY SHAKES; This spontaneous report received from a patient concerned a 38 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included addison's disease, and other pre-existing medical conditions included patient had not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced body ache. On 08-APR-2021, the subject experienced body shakes. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced severe fever. On 08-APR-2021, the subject experienced severe headaches. Laboratory data included: Body temperature (NR: not provided) 103 F. On 09-APR-2021, the subject experienced stomach aches. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body shakes on 09-APR-2021, had not recovered from severe fever, chills, severe headaches, and stomach aches, and the outcome of body ache was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo positional
Clinical narrative: POSITIONAL VERTIGO; LIGHTHEADED AND DIZZINESS; This spontaneous report received from a patient concerned a 70 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient reported for unknown allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070, and expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-MAR-2021, the subject experienced positional vertigo. On 23-MAR-2021, the subject experienced lightheaded and dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the positional vertigo and lightheaded and dizziness was not reported. This report was non-serious.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Headache, Pyrexia
Clinical narrative: BACK ACHE; FEVER; HEADACHE; This spontaneous report received from a patient concerned a 40 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201a21a, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-APR-2021, the subject experienced fever. On 09-APR-2021, the subject experienced headache. On 11-APR-2021, the subject experienced back ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and headache on 10-APR-2021, and had not recovered from back ache. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pain, Pain in extremity
Clinical narrative: BODY ACHE; CHILLS; LEG PAIN; BRUTAL HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced nausea. On 09-APR-2021, the subject experienced body ache. On 09-APR-2021, the subject experienced chills. On 09-APR-2021, the subject experienced leg pain. On 09-APR-2021, the subject experienced brutal headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the brutal headache, chills, leg pain, body ache and nausea was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: SEVERE DIZZINESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-APR-2021, the subject experienced severe dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of severe dizziness was not reported. This report was non-serious.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Muscle spasms, Nausea, Pyrexia
Clinical narrative: MUSCLE SPASMS; NAUSEA; FEVER; HEADACHE; This spontaneous report received from a consumer concerned a 23 year old female. The patient's height, and weight were not reported. The patient's past medical history included severe acid reflux, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 18:30 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced muscle spasms. On 10-APR-2021, the subject experienced nausea. On 10-APR-2021, the subject experienced fever. On 10-APR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 102 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from nausea, and had not recovered from fever, muscle spasms, and headache. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea
Clinical narrative: CHILLS; HEADACHE; SEVERE NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced severe nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe nausea, and the outcome of chills and headache was not reported. This report was non-serious.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: FEVER; CHILLS; This spontaneous report received from a patient concerned a 48 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and alcohol user, and other pre-existing medical conditions included the patient had no known allergies and had no drug abuse or illicit drug usage.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-APR-2021, the subject experienced chills. On 09-APR-2021 18:00, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, and chills. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered, Off label use
Clinical narrative: OFF LABEL USE; INAPPROPRIATE DOSE OF VACCINE ADMINISTERED; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A expiry: UNKNOWN) 1 ml, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced inappropriate dose of vaccine administered. On an unspecified date, the subject experienced off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the off label use and inappropriate dose of vaccine administered was not reported. This report was non-serious. This case, from the same reporter is linked to 20210416254.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain
Clinical narrative: BODY ACHES; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination.  The batch number was not reported and has been requested.  Concomitant medications included ibuprofen. On 09-APR-2021, the patient experienced body aches. On 09-APR-2021, the patient experienced headache. On 09-APR-2021, the patient experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body aches, headache, and nausea. This report was non-serious.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain
Clinical narrative: ACHES; CHILLS; TIREDNESS; This spontaneous report received from a patient via a company representative concerned a 61 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced aches. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from aches, chills, and tiredness on 11-APR-2021. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Nausea, Pain
Clinical narrative: BODY ACHES; CHILLS; FEVER; HEADACHE; NAUSEA; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 08:00 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, Laboratory data included: Body temperature (NR: not provided) 102 F.  On 06-APR-2021, the subject experienced body aches. On 06-APR-2021, the subject experienced chills. On 06-APR-2021, the subject experienced fever. On 06-APR-2021, the subject experienced headache. On 06-APR-2021, the subject experienced nausea.  Treatment medications (dates unspecified) included: acetylsalicylic acid/caffeine/paracetamol/ salicylamide. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, headache, body aches and nausea was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: BODY ACHES; CHILLS; FEVER; HEADACHE; NAUSEA; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 08:00 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, Laboratory data included: Body temperature (NR: not provided) 102 F.  On 06-APR-2021, the subject experienced body aches. On 06-APR-2021, the subject experienced chills. On 06-APR-2021, the subject experienced fever. On 06-APR-2021, the subject experienced headache. On 06-APR-2021, the subject experienced nausea.  Treatment medications (dates unspecified) included: acetylsalicylic acid/caffeine/paracetamol/ salicylamide. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, headache, body aches and nausea was not reported. This report was non-serious.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Dizziness, Hot flush, Hypertension, Oxygen saturation
Clinical narrative: Dizzy; HOT FLUSHES FACIAL; ELEVATED BLOOD PRESSURE; This spontaneous report received from a pharmacist concerned a 40 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known medication and food allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 043A21A, and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 14:03 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021 14:15, the subject experienced dizzy. On 10-APR-2021 14:15, the subject experienced hot flushes facial. On 10-APR-2021 14:15, the subject experienced elevated blood pressure. Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) elevated, and Oxygen saturation (NR: not provided) Normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from elevated blood pressure, had not recovered from dizzy, and the outcome of hot flushes facial was not reported. This report was non-serious.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Dizziness, Flushing, Oxygen saturation normal
Clinical narrative: Dizzy; HOT FLUSHES FACIAL; ELEVATED BLOOD PRESSURE; This spontaneous report received from a pharmacist concerned a 40 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known medication and food allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 043A21A, and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 14:03 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021 14:15, the subject experienced dizzy. On 10-APR-2021 14:15, the subject experienced hot flushes facial. On 10-APR-2021 14:15, the subject experienced elevated blood pressure. Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) elevated, and Oxygen saturation (NR: not provided) Normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from elevated blood pressure, had not recovered from dizzy, and the outcome of hot flushes facial was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Feeling cold, Injection site inflammation
Clinical narrative: STOMACH ACHE; DIARRHEA; FELT SO COLD; LITTLE SPOT OF LOCAL INFLAMMATION LIKE A PENCIL CHIP; This spontaneous report received from a patient concerned an 80 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included l5 fracture. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the subject experienced little spot of local inflammation like a pencil chip. On 03-APR-2021, the subject experienced stomach ache. On 03-APR-2021, the subject experienced diarrhea. On 03-APR-2021, the subject experienced felt so cold. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stomach ache, diarrhea, and felt so cold on 04-APR-2021, and was recovering from little spot of local inflammation like a pencil chip. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: RECURRENT FEVER; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. Batch number was not reported. The Company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported.  On 09-APR-2021, the subject experienced recurrent fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from recurrent fever. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia, Tremor
Clinical narrative: BODY ACHES; SHAKING; CHILLS; FEVER; This spontaneous report received from a parent concerned an 18 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced body aches. On 10-APR-2021, the subject experienced shaking. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, fever, body aches, and shaking. This report was non-serious.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: CHILLS; FEVER; This spontaneous report received from a consumer concerned a 46 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-APR-2021, the subject experienced chills. On 11-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, and chills. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: FEVER; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 102 to 103. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of fever was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Body temperature, Dizziness, Fatigue, Hyperhidrosis
Clinical narrative: LOW GRADE FEVER; KNOTS IN STOMACH; SORE ARM; SWEATING PROFUSELY; LIGHTHEADED; FEELING TIRED; This spontaneous report received from a patient concerned a 59 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced sweating profusely. On 08-APR-2021, the subject experienced lightheaded. On 08-APR-2021, the subject experienced sore arm. On 08-APR-2021, the subject experienced feeling tired. On 09-APR-2021 17:00, the subject experienced knots in stomach. On 10-APR-2021, the subject experienced low grade fever. Laboratory data included: Body temperature (NR: not provided) 100 degrees. On 11-APR-2021, Laboratory data included: Body temperature (NR: not provided) 99.5. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating profusely, and lightheaded on 08-APR-2021, and knots in stomach on 09-APR-2021, was recovering from sore arm, and low grade fever, and had not recovered from feeling tired. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: LOW GRADE FEVER; KNOTS IN STOMACH; SORE ARM; SWEATING PROFUSELY; LIGHTHEADED; FEELING TIRED; This spontaneous report received from a patient concerned a 59 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced sweating profusely. On 08-APR-2021, the subject experienced lightheaded. On 08-APR-2021, the subject experienced sore arm. On 08-APR-2021, the subject experienced feeling tired. On 09-APR-2021 17:00, the subject experienced knots in stomach. On 10-APR-2021, the subject experienced low grade fever. Laboratory data included: Body temperature (NR: not provided) 100 degrees. On 11-APR-2021, Laboratory data included: Body temperature (NR: not provided) 99.5. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating profusely, and lightheaded on 08-APR-2021, and knots in stomach on 09-APR-2021, was recovering from sore arm, and low grade fever, and had not recovered from feeling tired. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Hyperhidrosis, Nausea, Pain
Clinical narrative: LOW GRADE FEVER; KNOTS IN STOMACH; SORE ARM; SWEATING PROFUSELY; LIGHTHEADED; FEELING TIRED; This spontaneous report received from a patient concerned a 59 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced sweating profusely. On 08-APR-2021, the subject experienced lightheaded. On 08-APR-2021, the subject experienced sore arm. On 08-APR-2021, the subject experienced feeling tired. On 09-APR-2021 17:00, the subject experienced knots in stomach. On 10-APR-2021, the subject experienced low grade fever. Laboratory data included: Body temperature (NR: not provided) 100 degrees. On 11-APR-2021, Laboratory data included: Body temperature (NR: not provided) 99.5. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating profusely, and lightheaded on 08-APR-2021, and knots in stomach on 09-APR-2021, was recovering from sore arm, and low grade fever, and had not recovered from feeling tired. This report was non-serious.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Body temperature, Dizziness, Fatigue, Hyperhidrosis
Clinical narrative: WITHIN 6 MINUTES OF GETTING VACCINATION, BEGAN SWEATING PROFUSELY AND BECAME LIGHT HEADED. PHARMACY CLERK OFFERED ME WATER, FELT BETTER AFTER DRINKING WATER. NEXT DAY 4-9-21 ABOUT 5:00PM FELT EXTREMELY ACHY AND DEVELOPED STOMACH NAUSEA. HAD TEMPERATURE OF 100 DEGREES (NORMAL FOR ME IS 97-97.5 DEGREES) FELT TIRED. ACHES AND NAUSEA HAS SUBSIDED, BUT AT EIGHT DAYS AFTER VACCINATION TEMPERATURE IS STILL ELEVATED AT 99+ DEGREES. HAS NOT RETURNED TO NORMAL. DOCTOR IS CHECKING WITH PHARMACY TO DETERMINE IF I CAN SWITCH FROM TYLENOL TO IBUPROFEN. WILL ADVISE 4-16-21. HAVE BEEN IN CONTACT WITH MY DOCTOR AND STAFF SINCE 4-10-21. HAD VIDEO VISIT WITH MY DOCTOR TODAY (4-15-21).
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: WITHIN 6 MINUTES OF GETTING VACCINATION, BEGAN SWEATING PROFUSELY AND BECAME LIGHT HEADED. PHARMACY CLERK OFFERED ME WATER, FELT BETTER AFTER DRINKING WATER. NEXT DAY 4-9-21 ABOUT 5:00PM FELT EXTREMELY ACHY AND DEVELOPED STOMACH NAUSEA. HAD TEMPERATURE OF 100 DEGREES (NORMAL FOR ME IS 97-97.5 DEGREES) FELT TIRED. ACHES AND NAUSEA HAS SUBSIDED, BUT AT EIGHT DAYS AFTER VACCINATION TEMPERATURE IS STILL ELEVATED AT 99+ DEGREES. HAS NOT RETURNED TO NORMAL. DOCTOR IS CHECKING WITH PHARMACY TO DETERMINE IF I CAN SWITCH FROM TYLENOL TO IBUPROFEN. WILL ADVISE 4-16-21. HAVE BEEN IN CONTACT WITH MY DOCTOR AND STAFF SINCE 4-10-21. HAD VIDEO VISIT WITH MY DOCTOR TODAY (4-15-21).
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Hyperhidrosis, Nausea, Pain
Clinical narrative: WITHIN 6 MINUTES OF GETTING VACCINATION, BEGAN SWEATING PROFUSELY AND BECAME LIGHT HEADED. PHARMACY CLERK OFFERED ME WATER, FELT BETTER AFTER DRINKING WATER. NEXT DAY 4-9-21 ABOUT 5:00PM FELT EXTREMELY ACHY AND DEVELOPED STOMACH NAUSEA. HAD TEMPERATURE OF 100 DEGREES (NORMAL FOR ME IS 97-97.5 DEGREES) FELT TIRED. ACHES AND NAUSEA HAS SUBSIDED, BUT AT EIGHT DAYS AFTER VACCINATION TEMPERATURE IS STILL ELEVATED AT 99+ DEGREES. HAS NOT RETURNED TO NORMAL. DOCTOR IS CHECKING WITH PHARMACY TO DETERMINE IF I CAN SWITCH FROM TYLENOL TO IBUPROFEN. WILL ADVISE 4-16-21. HAVE BEEN IN CONTACT WITH MY DOCTOR AND STAFF SINCE 4-10-21. HAD VIDEO VISIT WITH MY DOCTOR TODAY (4-15-21).
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pain, Pyrexia
Clinical narrative: BODY ACHES; VOMITING; CHILLS; FEVER; FATIGUE; NAUSEA; This spontaneous report received from a patient concerned a 23 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 09:30 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced body aches. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced fatigue. On APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, fatigue, body aches, nausea, and vomiting. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: BODY ACHES; VOMITING; CHILLS; FEVER; FATIGUE; NAUSEA; This spontaneous report received from a patient concerned a 23 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 09:30 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced body aches. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced fatigue. On APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, fatigue, body aches, nausea, and vomiting. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Fatigue, Nausea, Pain
Clinical narrative: NAUSEA; ACHY; TIRED; FEVER; WEAKNESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin and batch number was not reported) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced weakness. Laboratory data included: Body temperature (NR: not provided) 101.4 F. On 08-APR-2021, the subject experienced achy. On 08-APR-2021, the subject experienced tired. On 08-APR-2021, the subject experienced fever. On 09-APR-2021, the subject experienced nausea. Laboratory data included: Body temperature (NR: not provided) 99.7 F, 100.2 F. Treatment medications included: paracetamol. On 09-APR-2021 04:30, Laboratory data included: Body temperature (NR: not provided) 100.2 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever and the outcome of achy, tired, weakness and nausea was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: NAUSEA; ACHY; TIRED; FEVER; WEAKNESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin and batch number was not reported) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced weakness. Laboratory data included: Body temperature (NR: not provided) 101.4 F. On 08-APR-2021, the subject experienced achy. On 08-APR-2021, the subject experienced tired. On 08-APR-2021, the subject experienced fever. On 09-APR-2021, the subject experienced nausea. Laboratory data included: Body temperature (NR: not provided) 99.7 F, 100.2 F. Treatment medications included: paracetamol. On 09-APR-2021 04:30, Laboratory data included: Body temperature (NR: not provided) 100.2 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever and the outcome of achy, tired, weakness and nausea was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Nausea
Clinical narrative: HIP AND SEVERE JOINT PAIN; MUSCLE ACHES; NAUSEA; TIRED AND KIND OF WEEK; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 16:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced muscle aches. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced tired and kind of week. On 09-APR-2021, the subject experienced hip and severe joint pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the muscle aches, nausea, tired and kind of week and hip and severe joint pain was not reported. This report was non-serious.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Feeling cold, Headache, Injection site mass
Clinical narrative: SEVERE BODY PAIN; BUMP AT INJECTION SITE; BURNING SENSATION IN ARM; FEELING COLD INSIDE BODY; CHILLS; NAUSEA; MUSCLE PAIN; HEADACHE; This spontaneous report received from a patient concerned a 52 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 14:00 for prophylactic vaccination. No concomitant medications were reported.  On 05-APR-2021, the subject experienced bump at injection site. On 05-APR-2021, the subject experienced burning sensation in arm. On 05-APR-2021, the subject experienced feeling cold inside body. On 05-APR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced nausea. On 05-APR-2021, the subject experienced muscle pain. On 05-APR-2021, the subject experienced headache. On 05-APR-2021 23:30, the subject experienced severe body pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from severe body pain, burning sensation in arm, and muscle pain on APR-2021, and had not recovered from nausea, chills, feeling cold inside body, bump at injection site, and headache. This report was non-serious.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain
Clinical narrative: SEVERE BODY PAIN; BUMP AT INJECTION SITE; BURNING SENSATION IN ARM; FEELING COLD INSIDE BODY; CHILLS; NAUSEA; MUSCLE PAIN; HEADACHE; This spontaneous report received from a patient concerned a 52 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 14:00 for prophylactic vaccination. No concomitant medications were reported.  On 05-APR-2021, the subject experienced bump at injection site. On 05-APR-2021, the subject experienced burning sensation in arm. On 05-APR-2021, the subject experienced feeling cold inside body. On 05-APR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced nausea. On 05-APR-2021, the subject experienced muscle pain. On 05-APR-2021, the subject experienced headache. On 05-APR-2021 23:30, the subject experienced severe body pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from severe body pain, burning sensation in arm, and muscle pain on APR-2021, and had not recovered from nausea, chills, feeling cold inside body, bump at injection site, and headache. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: SLIGHT FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced slight fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slight fever. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Culture, Headache, Neck pain
Clinical narrative: QUICK PULSE IN THROAT; NECK PAIN; LEFT SHOULDER PAIN; FEELING WEAK; HEADACHE; This spontaneous report received from a patient concerned a 70 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes, and high blood pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 2022LA, and batch number: 2022LA expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 11-APR-2021, the subject experienced quick pulse in throat. On 11-APR-2021, the subject experienced neck pain. On 11-APR-2021, the subject experienced left shoulder pain. On 11-APR-2021, the subject experienced feeling weak. On 11-APR-2021, the subject experienced headache. Laboratory data (dates unspecified) included: Culture nose (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from feeling weak, quick pulse in throat, headache, left shoulder pain, and neck pain. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort
Clinical narrative: QUICK PULSE IN THROAT; NECK PAIN; LEFT SHOULDER PAIN; FEELING WEAK; HEADACHE; This spontaneous report received from a patient concerned a 70 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes, and high blood pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 2022LA, and batch number: 2022LA expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 11-APR-2021, the subject experienced quick pulse in throat. On 11-APR-2021, the subject experienced neck pain. On 11-APR-2021, the subject experienced left shoulder pain. On 11-APR-2021, the subject experienced feeling weak. On 11-APR-2021, the subject experienced headache. Laboratory data (dates unspecified) included: Culture nose (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from feeling weak, quick pulse in throat, headache, left shoulder pain, and neck pain. This report was non-serious.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Malaise
Clinical narrative: RUNDOWN; TIRED; This spontaneous report received from a consumer concerned an 87 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 18:00 for prophylactic vaccination. The batch was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced rundown. On APR-2021, the subject experienced tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tired and rundown was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Influenza like illness, Pyrexia
Clinical narrative: SEVERE FLU LIKE SIDE EFFECTS; JOINT PAIN; HEADACHE; HIGH FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. As per procedure no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced severe flu like side effects, joint pain, headache, and high fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from severe flu like side effects, joint pain, headache, and high fever. This report was non-serious.